 small trial by Sarac et al,238 56 patients undergoing
high-risk vein bypass (deﬁned as poor-quality conduit or
runoff) were randomized to ASA plus warfarin vs ASA
alone. The patients receiving ASA plus warfarin had a
signiﬁcantly improved patency and limb salvage at 3 years.
The ischemic consequences of graft thrombosis may be
ameliorated by the use of anticoagulants after bypass